EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Survival Differences in Patients with High-Flux Hemodialysis versus Expanded Hemodialysis: A Cohort Study

Juan C Castillo, Jasmin Vesga, Angela Rivera, Peter Rutherford, Ricardo Sanchez, Henry Oliveros, Bengt Lindholm, Mauricio Sanabria

Blood Purification · 2025

DOI: 10.1159/000548158 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Blood Purification, 2025. Verfasst von Juan C Castillo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Renal Care Services Soacha, Bogota DC, Colombia. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19, Kidney Failure, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Survival is a core outcome of hemodialysis (HD) therapy. Expanded hemodialysis (HDx) enabled by Theranova dialyzer increases clearance of medium-sized molecules and was reported to improve various patient-reported outcomes compared to HD using high-flux membranes, but the impact on survival is unclear. Herein, we evaluated the risk of death for HDx versus high-flux HD over a 4-year follow-up period.

Methods

This is a multicenter, retrospective cohort study in adult prevalent chronic HD at Renal Care Services – Colombia starting between September 1, 2017, and November 30, 2017, with follow-up for up to 4 years. The sociodemographic and clinical characteristics of all patients were summarized descriptively. The Fine-Gray subdistribution hazard model was employed to evaluate the sub-hazard ratio of factors associated with time to death from causes other than COVID-19; death attributable to COVID-19 was considered as a competing risk. Sensitivity analyses included Cox proportional hazards model, extended Cox regression, and Cox regression after adjusting for imbalances between cohorts using the inverse probability of treatment weighting method.

Results

We evaluated 1,092 patients, 559 in HDx cohort and 533 in high-flux HD cohort; the mean age 61 years; 42% had diabetes, and 19% had cardiovascular disease. HDx using the Theranova dialyzer had a protective effect with reduction of mortality risk when controlling for confounding variables, SHR = 0.79 [95% CI: 0.62–0.98, p = 0.035]. Sensitivity analyses also showed a statistically significant beneficial effect of HDx versus high-flux HD.

Conclusions

HDx enabled by Theranova dialyzer was associated with an approximately 21% reduction in mortality risk compared to treatment with high-flux HD in patients followed for up to 4 years. It would be desirable for these very promising results to be corroborated by a randomized controlled trial, with sufficient follow-up time to investigate the effect described in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCOVID-19Kidney Failure, ChronicHumansMiddle AgedMaleFemaleRetrospective StudiesAgedSARS-CoV-2AdultColombiaProportional Hazards ModelsFollow-Up StudiesCohort Studies

Stichwörter der Autor:innen

Expanded hemodialysis therapyHemodialysisHigh-flux hemodialysisKidney failureSurvivalTheranova dialyzer

Autor:innen und Institutionen

  • Renal Care Services Soacha, Bogota DC, Colombia.
  • Renal Care Services Colombia, Bucaramanga, Colombia.
  • Vantive, Deerfield, Illinois, USA.
  • Vantive, Zurich, Switzerland.
  • Clinical Research Institute, Faculty of Medicine, National University of Colombia, Bogota DC, Colombia.
  • Faculty of Medicine, Sabana University, Bogota DC, Colombia.

Zitieren

APA

Castillo, J. C., Vesga, J., Rivera, A., Rutherford, P., Sanchez, R., Oliveros, H., Lindholm, B., & Sanabria, M. (2025). Survival Differences in Patients with High-Flux Hemodialysis versus Expanded Hemodialysis: A Cohort Study. Blood Purification. https://doi.org/10.1159/000548158

Vancouver

Castillo JC, Vesga J, Rivera A, Rutherford P, Sanchez R, Oliveros H, et al. Survival Differences in Patients with High-Flux Hemodialysis versus Expanded Hemodialysis: A Cohort Study. Blood Purification. 2025. doi:10.1159/000548158

BibTeX
@article{Castillo2025,
  author = {Castillo, Juan C and Vesga, Jasmin and Rivera, Angela and Rutherford, Peter and Sanchez, Ricardo and Oliveros, Henry and Lindholm, Bengt and Sanabria, Mauricio},
  title = {Survival Differences in Patients with High-Flux Hemodialysis versus Expanded Hemodialysis: A Cohort Study},
  journal = {Blood Purification},
  year = {2025},
  doi = {10.1159/000548158}
}
Kostenlos starten →